risks of compounded semaglutide The FDA Warns the Using May Entail FDA's Semaglutide Shortage Resolution: Legal
Description
To continue receiving the medication and the prescription weight loss program, patients will need to comply with monthly in-office visits

Rare but serious complications may include pancreatitis, gallbladder disease, kidney impairment, and potential risks of thyroid tumors , which were identified in animal studies

There are patients we will not prescribe it to, and we would rather say so upfront than waste a consult

General hydration guidance, not a GLP-1-specific rule, is the place to start, and your doctor can tailor it
RESULTS IN WEEKS, NOT MONTHS Most users report fewer cravings, better digestion, and early weight loss within the first 2 weeks

Listeners will learn who may qualify, how the proposed $50 monthly cost could work during the temporary Bridge Program, and why coverage could change once insurance plans become involved in 2027
